Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma: final analysis of KEYNOTE-170

por Zinzani, Pier Luigi, Thieblemont, Catherine, Melnichenko, Vladimir, Bouabdallah, Krimo, Walewski, Jan, Majlis, Alejandro, Fogliatto, Laura, Garcia-Sancho, A. Martin, Christian, Beth, Gulbas, Zafer, Özcan, Muhit, Perini, Guilherme Fleury, Ghesquieres, Herve, Shipp, Margaret A., Thompson, Seth, Chakraborty, Samhita, Marinello, Patricia, Armand, Philippe
Publicado 2023

Mutational Landscape and Actionable Target Rates on Advanced Stage Refractory Cancer Patients: A Multicenter Chilean Experience

por Cordova-Delgado, Miguel, Pinto, Mauricio P., Regonesi, Carlos, Cereceda, Luis, Reyes, José Miguel, Itriago, Laura, Majlis, Alejandro, Rodríguez, Pablo, Fassler, André, Mahave, Mauricio, León, María Elisa, Gallardo, Jorge, Rodríguez Z., María Paz, Berkovits, Alejandro, Manque, Patricio, Ríos, Juvenal A., Garcia-Bloj, Benjamín, Garrido, Marcelo
Publicado 2022